Concepedia

Avital Beig

AB

Statistics

Publications

26

Citations

1.7K

H-Index

20

Active since

2011

Affiliations

Ben-Gurion University of the Negev(Current)

AbbVie (United States)

University of Michigan

Abbott Fund

BioSurfaces (United States)

Avital Beig is an author at Ben-Gurion University of the Negev specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2011–2022

26

Publications

26

A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Jonathan M. Miller, Avital Beig, Robert A. Carr et al. · Molecular Pharmaceutics · 2012 · 250 citations

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Jonathan M. Miller, Avital Beig, Brian J. Krieg et al. · Molecular Pharmaceutics · 2011 · 200 citations

, , +15

Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations

Avital Beig, Riad Agbaria, Arik Dahan · PLoS ONE · 2013 · 129 citations · Full text

The Solubility–Permeability Interplay When Using Cosolvents for Solubilization: Revising the Way We Use Solubility-Enabling Formulations

Jonathan M. Miller, Avital Beig, Robert Carr et al. · Molecular Pharmaceutics · 2012 · 129 citations

, , +16

Accounting for the solubility–permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption

Avital Beig, Jonathan M. Miller, Arik Dahan · European Journal of Pharmaceutics and Biopharmaceutics · 2012 · 103 citations

, , +8

1–5 of 26